COLLEEN KARASINSKI: Open Payments
NPI 1013171206 · SOMERS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 36 payments from 7 companies in 2025. Trend: 2023 $950 · 2024 $915 · 2025 $1,443
Food & beverage: $1,443
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $583 |
| Neurocrine BioSciences, Inc. | 4 | $275 |
| Axsome Therapeutics, Inc. | 4 | $250 |
| Otsuka America Pharmaceutical, Inc. | 9 | $216 |
| Alkermes, Inc. | 4 | $70 |
| ABBVIE INC. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: CAPLYTA, INGREZZA, Auvelity, REXULTI, VIVITROL, VRAYLAR, TRINTELLIX, ARISTADA.
Industry payments across NJ — which companies pay providers there.
